Revenue
$24.1M
Net Income
-$243.3M
▲ 17.3% YoY
EPS
$-2.86
▲ 72.4% YoY
Cash
$89.7M
▼ 47.1% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Schroer John R. Chief Financial Officer | Sell | Aug 3, 2026 | 3.3K | $26.37 | $87K | Form 4 ↗ |
Pangali Sanam Chief Legal Officer | Sell | Aug 3, 2026 | 1.4K | $26.37 | $36K | Form 4 ↗ |
Hardiman Roy C. Chief Business & Strategy Ofcr | Sell | Aug 3, 2026 | 2.7K | $26.37 | $71K | Form 4 ↗ |
Goldstein David M Chief Scientific Officer | Sell | Aug 3, 2026 | 2.6K | $26.37 | $68K | Form 4 ↗ |
Drappa Jorn Chief Medical Officer | Sell | Aug 3, 2026 | 2.4K | $26.37 | $65K | Form 4 ↗ |
Bradley Mark Christopher Chief Development Officer | Sell | Aug 3, 2026 | 2.6K | $26.37 | $68K | Form 4 ↗ |
Pangali Sanam Chief Legal Officer | Vest | Jul 6, 2026 | 5.0K | $5.06 | $25K | Form 4 ↗ |
Pangali Sanam Chief Legal Officer | Sell | Jul 6, 2026 | 5.0K | $28.00 | $140K | Form 4 ↗ |
TETRAULT LYNN A. | Grant | Jun 30, 2026 | 3.6K | $0.00 | $0 | Form 4 ↗ |
Yao Zhengbin | Grant | Jun 30, 2026 | 3.6K | $0.00 | $0 | Form 4 ↗ |
Srivastava Sapna | Grant | Jun 30, 2026 | 3.6K | $0.00 | $0 | Form 4 ↗ |
Machado Patrick | Grant | Jun 30, 2026 | 3.6K | $0.00 | $0 | Form 4 ↗ |
AKKARAJU SRINIVAS | Grant | Jun 30, 2026 | 3.6K | $0.00 | $0 | Form 4 ↗ |